SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 142 | 1 | 147 | +6 |
| Shares | 69.6M | 1.06M | 68.5M | −108.2K (−0.2%) |
| Value | $1.82B | $27.8M | $1.58B | −$214.5M (−12.0%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 1,053,857 | $24.4M | 0.03% |
| Maverick Capital LtdSuperinvestorMaverick Capital | 637,760 | $14.7M | 0.34% |
| Ikarian Capital, LLC | 178,360 | $4.12M | 1.53% |
| Twinbeech Capital LP | 122,429 | $2.83M | 0.05% |
| Millennium Management LLC | 114,923 | $2.66M | 0.00% |
| Balyasny Asset Management LLC | 47,218 | $1.09M | 0.00% |
| Victory Capital Management Inc | 41,240 | $953.5K | 0.00% |
| Boothbay Fund Management, LLC | 38,447 | $888.9K | 0.03% |
| Squarepoint Ops LLC | 33,768 | $780.7K | 0.00% |
| Financial Security Advisor, Inc. | 31,758 | $734.2K | 0.34% |
| ExodusPoint Capital Management, LP | 27,022 | $625.0K | 0.01% |
| Walleye Trading LLC | 8,242 | $190.6K | 0.00% |
| Quarry LP | 4,519 | $104.5K | 0.07% |
| Simplex Trading, LLC | 467 | $10.0K | 0.00% |
| FinTrust Capital Advisors, LLC | 20 | $463 | 0.00% |
| Bell Investment Advisors, Inc | 18 | $417 | 0.00% |
| Larson Financial Group LLC | 9 | $208 | 0.00% |
Sold out (11)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Weiss Multi-Strategy Advisers LLC | 73,396 | $1.92M |
| Ghost Tree Capital, LLC | 27,578 | $723.1K |
| Qube Research & Technologies Ltd | 22,549 | $591.2K |
| Tudor Investment Corp Et Al | 21,197 | $555.8K |
| Healthcare of Ontario Pension Plan Trust Fund | 15,000 | $393.3K |
| Ergoteles LLC | 14,700 | $385.4K |
| Thrivent Financial for Lutherans | 12,745 | $334.0K |
| HighVista Strategies LLC | 11,688 | $306.5K |
| Innovis Asset Management LLC | 8,613 | $225.8K |
| Snowden Capital Advisors LLC | 7,898 | $207.1K |
| Group One Trading, L.P. | 1,316 | $34.5K |
Not filed for Q3 2023 yet (1)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 1,061,538 | $27.8M |